Health & Fitness
Health and Fitness
Health and Fitness
Fri, October 21, 2011
Thu, October 20, 2011
Exelixis Announces October 27th Webcast of Third Quarter 2011 Financial Results Conference Call
SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (NASDAQ:EXEL) will release its third quarter 2011 financial results on Thursday, October 27, 2011, after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT. During the webcast, Exelixis management will discuss the Companya™s financial results, financial outlook and development program and plans for cabozantinib, and also provide a general business update The webcast may be accessed in the Event Calendar page under Investors at [ http://www.exelixis.com ].
An archived replay of the webcast will be available on the Event Calendar page under Investors at [ http://www.exelixis.com ] and via phone until 11:59 p.m. EST on November 27, 2011. Access numbers for the phone replay are: 888-286-8010 (domestic) and 617-801-6888 (international); the passcode is 64691635.
About Exelixis
Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the company's web site at [ http://www.exelixis.com ].
